Research demonstrates enhanced bioactivity of modified corn silk polysaccharides, suggesting potential applications in health.
The extraction methods significantly affect the yield and structure of polysaccharides. Based on single-factor experiments, response surface methodology optimized ultrasound-assisted extraction conditions for corn silk polysaccharides (CSP): liquid-to-solid 43 mL/g, extraction time 3 h, and ultrasonic power 640 W, yielding 5.83% CSP. Sulfated, phosphorylated, and selenylated derivatives (CSP-S, CSP-P, and CSP-Se) were prepared with substitution degrees of 0.6 and 0.4, and selenium content of 5.3%, respectively. After confirming structures by UV, FT-IR, SEM, monosaccharide, and Congo-red analyses, the bioactivities of the modified CSP were compared. All derivatives improved antioxidant capacity in vitro: phosphorylation boosted DPPH scavenging, while sulfation enhanced hydroxyl and superoxide anion radical elimination. Selenylation markedly inhibited the activities of α-amylase and lipase, and promoted glucose consumption in HepG2 cells, demonstrating hypoglycemic potential. Moreover, all polysaccharides enhanced RAW264.7 cell viability, phagocytosis, and nitric oxide (NO) release, with CSP-S being most effective. Chemical modifications markedly improved CSP bioactivities, highlighting their application prospects.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: